Tags

Type your tag names separated by a space and hit enter

[From Axial Spondyloarthritis to Osteoporosis - Spectrum of Skeletal Involvement in Inflammatory Bowel Diseases].
Praxis (Bern 1994) 2019; 108(12):799-806P

Abstract

From Axial Spondyloarthritis to Osteoporosis - Spectrum of Skeletal Involvement in Inflammatory Bowel Diseases Abstract. Inflammatory bowel diseases (IBD) are frequently accompanied by non-inflammatory joint pain and inflammatory spondyloarthritides. Spondyloarthritides can restrict joint function and typically manifest with inflammatory back pain with nightly pain and morning stiffness that improves upon exercising. In other patients, small or large peripheral joints are predominantly involved. Treatment comprises pain medication including COX-II selective non-steroidal anti-inflammatory drugs (NSAID), since non-selective NSAID can aggravate IBD. For axial manifestations, physiotherapy and tumor necrosis factor (TNF) inhibitors are effective, while for peripheral manifestations steroid injections, sulfasalazine and TNF inhibitors are useful. Osteopenia and osteoporosis may result from inflammation, malabsorption and/or steroids. Long-lasting disease activity or steroid treatment should prompt osteoporosis screening. Adequate calcium and vitamin D intake must be ensured and treatment with bisphosphonates evaluated.

Authors+Show Affiliations

Klinik für Gastroenterologie und Hepatologie, Universitätsspital Zürich und Universität Zürich.Klinik für Rheumatologie, Universitätsspital Zürich und Universität Zürich.Klinik für Gastroenterologie und Hepatologie, Universitätsspital Zürich und Universität Zürich.Universitätsklinik für Viszerale Chirurgie und Medizin, Inselspital Bern.Klinik für Gastroenterologie und Hepatologie, Universitätsspital Zürich und Universität Zürich. GastroZentrum Hirslanden, Klinik Hirslanden, Zürich.GastroZentrum Hirslanden, Klinik Hirslanden, Zürich.Universitätsklinik für Rheumatologie, Immunologie und Allergologie, Inselspital Bern.Klinik für Gastroenterologie und Hepatologie, Universitätsspital Zürich und Universität Zürich.Klinik für Gastroenterologie und Hepatologie, Universitätsspital Zürich und Universität Zürich.

Pub Type(s)

Journal Article

Language

ger

PubMed ID

31530124

Citation

Schüle, Solvey, et al. "[From Axial Spondyloarthritis to Osteoporosis - Spectrum of Skeletal Involvement in Inflammatory Bowel Diseases]." Praxis, vol. 108, no. 12, 2019, pp. 799-806.
Schüle S, Frey D, Biedermann L, et al. [From Axial Spondyloarthritis to Osteoporosis - Spectrum of Skeletal Involvement in Inflammatory Bowel Diseases]. Praxis (Bern 1994). 2019;108(12):799-806.
Schüle, S., Frey, D., Biedermann, L., Grueber, M. M., Zeitz, J., Vavricka, S., ... Misselwitz, B. (2019). [From Axial Spondyloarthritis to Osteoporosis - Spectrum of Skeletal Involvement in Inflammatory Bowel Diseases]. Praxis, 108(12), pp. 799-806. doi:10.1024/1661-8157/a003301.
Schüle S, et al. [From Axial Spondyloarthritis to Osteoporosis - Spectrum of Skeletal Involvement in Inflammatory Bowel Diseases]. Praxis (Bern 1994). 2019;108(12):799-806. PubMed PMID: 31530124.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [From Axial Spondyloarthritis to Osteoporosis - Spectrum of Skeletal Involvement in Inflammatory Bowel Diseases]. AU - Schüle,Solvey, AU - Frey,Diana, AU - Biedermann,Luc, AU - Grueber,Maude Martinho, AU - Zeitz,Jonas, AU - Vavricka,Stephan, AU - Möller,Burkhard, AU - Rogler,Gerhard, AU - Misselwitz,Benjamin, PY - 2019/9/19/entrez PY - 2019/9/19/pubmed PY - 2019/10/15/medline KW - Arthralgie KW - Chronisch entzündliche Darmerkrankungen KW - Inflammatory bowel disease KW - Maladie inflammatoire chronique de l’intestin KW - Osteopenie KW - Osteoporose KW - arthralgia KW - arthropathie KW - axial spondyloarthritis KW - axiale Spondyloarthritis KW - extraintestinal manifestations KW - extraintestinale Manifestationen KW - manifestations extra-intestinales KW - osteopenia KW - osteoporosis KW - ostéoporose KW - ostéopénie SP - 799 EP - 806 JF - Praxis JO - Praxis (Bern 1994) VL - 108 IS - 12 N2 - From Axial Spondyloarthritis to Osteoporosis - Spectrum of Skeletal Involvement in Inflammatory Bowel Diseases Abstract. Inflammatory bowel diseases (IBD) are frequently accompanied by non-inflammatory joint pain and inflammatory spondyloarthritides. Spondyloarthritides can restrict joint function and typically manifest with inflammatory back pain with nightly pain and morning stiffness that improves upon exercising. In other patients, small or large peripheral joints are predominantly involved. Treatment comprises pain medication including COX-II selective non-steroidal anti-inflammatory drugs (NSAID), since non-selective NSAID can aggravate IBD. For axial manifestations, physiotherapy and tumor necrosis factor (TNF) inhibitors are effective, while for peripheral manifestations steroid injections, sulfasalazine and TNF inhibitors are useful. Osteopenia and osteoporosis may result from inflammation, malabsorption and/or steroids. Long-lasting disease activity or steroid treatment should prompt osteoporosis screening. Adequate calcium and vitamin D intake must be ensured and treatment with bisphosphonates evaluated. SN - 1661-8157 UR - https://www.unboundmedicine.com/medline/citation/31530124/[From_Axial_Spondyloarthritis_to_Osteoporosis_-_Spectrum_of_Skeletal_Involvement_in_Inflammatory_Bowel_Diseases] L2 - http://econtent.hogrefe.com/doi/full/10.1024/1661-8157/a003301?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed DB - PRIME DP - Unbound Medicine ER -